Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 13Not yet recruiting 5Completed 4Enrolling by invitation 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Genitourinary 5Other hematologic neoplasm 4Gastrointestinal 4Tumor-Agnostic 3Gynecologic 3Other solid neoplasm 1Other neoplasm 1Other 1Lymphoid 1Head & Neck 1

Conditions

Advanced Malignant Solid Neoplasm 1

Interventions

pembrolizumab 27Pemetrexed 10Nivolumab 10Cyclophosphamide 10Carboplatin 10atezolizumab 8Specimen Handling 8Cisplatin 8Ipilimumab 6Biopsy 6fludarabine 5Injections 5tislelizumab 4spartalizumab 4Vincristine 4Radiotherapy 4Proton Therapy 4Platinum 4Paclitaxel 4Drug Therapy 4Docetaxel 4Bevacizumab 41,2-diaminocyclohexaneplatinum II citrate 4sintilimab 3durvalumab 3Trastuzumab 3Etoposide 3Cetuximab 3zimberelimab 2trametinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Interviews as Topic × Other solid neoplasm × Clear all
NCT04989556 2025-10-14

Technology-Enhanced Palliative Care for Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase NA Active not recruiting
119 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡